After Hours
There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. Most recently, Yahoo Finance reported about the stock as it publicized that Neurocrine Biosciences Announces Conference Call and Webcast of First Quarter 2024 Financial Results.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Stocks Info
As a NASDAQ listed company, NBIX falls under the Healthcare sector while operating within the Drug Manufacturers – Specialty & Generic industry segment. At the end of the last regular session, the stock closed at $135.93 and fluctuated between $138.67 as its day high and $135.28 as its day low. The current market capitalization of Neurocrine Biosciences, Inc. is $13.53B. A total of 0.81 million shares were traded on the day, compared to an average of 876.93K shares.
In the most recent transaction, Delaet Ingrid sold 272 shares of NBIX for 137.30 per share on Apr 01 ’24. After the transaction, the Chief Regulatory Officer now owns 7,507 company shares. In a previous transaction on Mar 21 ’24, Delaet Ingrid sold 5,000 shares at 145.06 per share. NBIX shares that Chief Regulatory Officer owns now total 7,507.
Among the insiders who sold shares, BENEVICH ERIC disposed of 75,000 shares on Mar 14 ’24 at a per-share price of $139.38. This resulted in the Chief Commercial Officer holding 40,778 shares of NBIX after the transaction. In another insider transaction, MORROW GEORGE J sold 40,000 shares at $139.42 per share on Mar 14 ’24. Company shares held by the Director now total 0.
In spite of price targets being rarely accurate, it tends to exert some kind influence from time to time, and was often accepted by the market as having some value. In terms of 52-week highs and lows, NBIX has a high of $148.37 and a low of $89.04.
As of this writing, NBIX has an earnings estimate of $0.99 per share for the current quarter. EPS was calculated based on a consensus of 17 estimates, with a high estimate of $1.77 per share and a lower estimate of $0.21. The company reported an EPS of $0.82 in the last quarter, which was -15.50% lower than expectations of $0.97.
Balance Sheet Annually/Quarterly
The balance sheet of a company shows what assets and liabilities a company has, as well as the amount, equity investors have invested. With the help of this information, a company’s financial ratios can be calculated to give investors an overview of the company’s prospects. NBIX’s latest balance sheet shows that the firm has $711.30M in Cash & Short Term Investments as of fiscal 2021. There were $440.40M in debt and $245.80M in liabilities at the time. Its Book Value Per Share was $22.61, while its Total Shareholder’s Equity was $1.37B.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for NBIX is Buy with a score of 4.48.
